IL39821A - Betamethasone-and 9alpha-chlorobetamethasone 21-adamantoate - Google Patents

Betamethasone-and 9alpha-chlorobetamethasone 21-adamantoate

Info

Publication number
IL39821A
IL39821A IL39821A IL3982172A IL39821A IL 39821 A IL39821 A IL 39821A IL 39821 A IL39821 A IL 39821A IL 3982172 A IL3982172 A IL 3982172A IL 39821 A IL39821 A IL 39821A
Authority
IL
Israel
Prior art keywords
chlorobetamethasone
9alpha
adamantoate
betamethasone
Prior art date
Application number
IL39821A
Other languages
English (en)
Other versions
IL39821A0 (en
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of IL39821A0 publication Critical patent/IL39821A0/xx
Publication of IL39821A publication Critical patent/IL39821A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL39821A 1971-07-05 1972-07-04 Betamethasone-and 9alpha-chlorobetamethasone 21-adamantoate IL39821A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3134971A GB1391443A (en) 1971-07-05 1971-07-05 Ester of betamethasone and its 9alpha-chloro analogue

Publications (2)

Publication Number Publication Date
IL39821A0 IL39821A0 (en) 1972-09-28
IL39821A true IL39821A (en) 1976-02-29

Family

ID=10321802

Family Applications (1)

Application Number Title Priority Date Filing Date
IL39821A IL39821A (en) 1971-07-05 1972-07-04 Betamethasone-and 9alpha-chlorobetamethasone 21-adamantoate

Country Status (17)

Country Link
JP (1) JPS5644079B1 (xx)
AR (2) AR194120A1 (xx)
AU (1) AU464251B2 (xx)
BE (1) BE785812A (xx)
CA (1) CA983919A (xx)
CH (1) CH609065A5 (xx)
DE (1) DE2232827A1 (xx)
DK (1) DK131474B (xx)
FR (1) FR2144761B1 (xx)
GB (1) GB1391443A (xx)
IE (1) IE36529B1 (xx)
IL (1) IL39821A (xx)
NL (1) NL169882C (xx)
NO (1) NO137754C (xx)
PH (1) PH13195A (xx)
SE (1) SE385904B (xx)
ZA (1) ZA724598B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS49116217A (xx) * 1973-01-03 1974-11-06
SE418294B (sv) * 1974-03-27 1981-05-18 Plurichemie Anstalt Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester
JPS6163976U (xx) * 1984-10-01 1986-05-01
NZ589444A (en) 2008-05-28 2013-03-28 Validus Biopharma Inc NON-HORMONAL STEROID MODULATORS OF NF-Kappa B FOR TREATMENT OF DISEASE
EP2556083A4 (en) 2010-04-05 2013-12-04 Validus Biopharma Inc NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT
WO2017004205A1 (en) 2015-06-29 2017-01-05 Reveragen Biopharma, Inc. NON-HORMONAL STEROID MODULATORS OF NF-κB FOR TREATMENT OF DISEASE
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Also Published As

Publication number Publication date
AU464251B2 (en) 1975-08-21
SE385904B (sv) 1976-07-26
NO137754B (no) 1978-01-09
GB1391443A (en) 1975-04-23
JPS5644079B1 (xx) 1981-10-16
IL39821A0 (en) 1972-09-28
CH609065A5 (en) 1979-02-15
NO137754C (no) 1978-04-19
DE2232827A1 (de) 1973-01-18
FR2144761B1 (xx) 1976-03-05
PH13195A (en) 1980-01-18
ZA724598B (en) 1973-03-28
AU4420572A (en) 1974-01-10
AR194120A1 (es) 1973-06-22
CA983919A (en) 1976-02-17
NL169882B (nl) 1982-04-01
BE785812A (fr) 1973-01-04
IE36529L (en) 1973-01-05
IE36529B1 (en) 1976-11-24
DK131474B (da) 1975-07-21
FR2144761A1 (xx) 1973-02-16
AR194553A1 (es) 1973-07-23
DK131474C (xx) 1975-12-08
NL7209345A (xx) 1973-01-09
NL169882C (nl) 1982-09-01

Similar Documents

Publication Publication Date Title
JPS5154889A (en) Shokubaisakutaino seiho
JPS5167423A (en) Tekusuchayaanno seizoho
CY861A (en) Phenicillins
JPS5173153A (en) Ekijosutaataa narabini doseizoho
IE36750L (en) Triazolobenzothiazole
GB1406623A (en) Nitromethylcyclopentanones
EG10585A (en) Phenoxycarboxamides
GB1404022A (en) Dihydropyridazones
AU4916772A (en) Benzimidazolyl-2-aminoimidazolines
CY988A (en) Thienobenzazepines
IL39635A0 (en) Cinnamanilides
IL39821A (en) Betamethasone-and 9alpha-chlorobetamethasone 21-adamantoate
AU4209872A (en) Container-agitator
IE36289L (en) Diamino-benzylpyrimidines
GB1389829A (en) Clawrings
JPS5163721A (en) Taipuraitaano ribonkudosochi
GB1400755A (en) Benzodizepines
GB1400602A (en) 2-5-nitro-2-thazolyl-benzimidazoles
IE36520L (en) Pyrimidotriazines
GB1401975A (en) 3-trifluoromethyl-anilides
JPS5123560A (en) Horiakuriruamidono kosaketsugohoho
JPS516269A (en) Kyuasareta nyoso horumuarudehidozairyono seizohoho
IL40948A (en) Pgf2alpha-9-esters
IL39398A0 (en) N-aryl-ureas
CA34806S (en) Vahicle